No abstract available
Publication types
-
Clinical Trial, Phase III
-
Letter
MeSH terms
-
Analysis of Variance
-
Antibodies, Monoclonal, Humanized / administration & dosage*
-
Dermatologic Agents / administration & dosage*
-
Drug Administration Schedule
-
Drug Therapy, Combination
-
Etanercept / administration & dosage*
-
Humans
-
Patient Reported Outcome Measures
-
Psoriasis / drug therapy*
-
Quality of Life
-
Risk Factors
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Dermatologic Agents
-
ixekizumab
-
Etanercept